Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;57(9):4215-21.
doi: 10.1128/AAC.00493-13. Epub 2013 Jun 17.

Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa

Affiliations

Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa

Karin Meinike Jørgensen et al. Antimicrob Agents Chemother. 2013 Sep.

Abstract

The dynamics of occurrence and the genetic basis of ciprofloxacin resistance were studied in a long-term evolution experiment (940 generations) in wild-type, reference strain (PAO1) and hypermutable (PAOΔmutS and PAOMY-Mgm) P. aeruginosa populations continuously exposed to sub-MICs (1/4) of ciprofloxacin. A rapid occurrence of ciprofloxacin-resistant mutants (MIC of ≥12 μg/ml, representing 100 times the MIC of the original population) were observed in all ciprofloxacin-exposed lineages of PAOΔmutS and PAOMY-Mgm populations after 100 and 170 generations, respectively, and in one of the PAO1 lineages after 240 generations. The genetic basis of resistance was mutations in gyrA (C248T and G259T) and gyrB (C1397A). Cross-resistance to beta-lactam antibiotics was observed in the bacterial populations that evolved during exposure to sublethal concentrations of ciprofloxacin. Our study shows that mutants with high-level ciprofloxacin resistance are selected in P. aeruginosa bacterial populations exposed to sub-MICs of ciprofloxacin. This can have implications for the long-term persistence of resistant bacteria and spread of antibiotic resistance by exposure of commensal bacterial flora to low antibiotic concentrations.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Characterization of the susceptibility to ciprofloxacin of the bacterial population and assignment of population MIC values. To distinguish between different sizes of the resistant subpopulations that grew in the inhibition zone, four descriptive entities were defined: (i) “double zone” if the resistant colonies exhibit a confluent growth, (ii) +++ if the number of colonies was higher than 100, (iii) ++ if the number of colonies was between 10 and 100, and (iv) + if fewer than 10 colonies were present. The descriptions of the two bacterial populations in this figure are thus as follows: in the left panel, the population MIC is 1.5 μg/ml, there is no double zone (dz−), and the size of the resistant subpopulation is +++; in the right panel, the population MIC is 1.5 μg/ml, a double zone is present until 12 μg/ml (dz 12), and resistant colonies in the inhibition zone are also present (+).
Fig 2
Fig 2
Development of resistance to ciprofloxacin in ciprofloxacin-treated (top three rows) and untreated (bottom three rows) PAO1, PAOΔmutS, and PAOMY-Mgm during the evolution experiment. Resistant mutants occurred faster in the mutator populations than in PAO1, with an especially drastic increase in MICs for the ciprofloxacin-treated PAOΔmutS strains. Black bars, MICs of population; white bars, MICs of double zone; gray bars, MICs of resistant colonies. Notice the difference in the numerical size of the ordinates in the top three and bottom three rows.

Similar articles

Cited by

References

    1. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, Høiby N, Sommer MO, Molin S. 2011. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl. Acad. Sci. U. S. A. 108:7481–7486 - PMC - PubMed
    1. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251–1254 - PubMed
    1. Ciofu O, Riis B, Pressler T, Poulsen HE, Høiby N. 2005. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother. 49:2276–2282 - PMC - PubMed
    1. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797–810 - PubMed
    1. Morero NR, Monti MR, Argarana CE. 2011. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators. Antimicrob. Agents Chemother. 55:3668–3676 - PMC - PubMed

MeSH terms

LinkOut - more resources